Pulmonx paid its 4 named executives $10.2M in total in FY2025 (Dec). CEO Glendon E. French was paid $3.5M of that.
Pay$100 in the stock at the end of FY21 → $7
Pay of each named executive
Steven S. WilliamsonFormer Chief Executive Officer
| FY2024 (Dec) |
1 year
Glendon E. FrenchChief Executive Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
4 years
Derrick Sung, Ph.DChief Operating Officer and Chief Financial Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) |
3 years
Mehul JoshiFormer Chief Financial Officer
| FY2025 (Dec) | Low confidence | Low confidence | ||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) |
3 years
David LehmanGeneral Counsel
| FY2025 (Dec) | Low confidence | |||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
4 years
CEO pay against the pay peers
In FY2025 (Dec), the median CEO pay of the 6 peers with pay on file was $3.3M. CEO pay of Pulmonx for that year is not on file.
- 1Axogen
- 2Tactile Systems Technology
- 3Orthopediatrics
- 4Outset Medical
- 5ClearPoint Neuro
- 6Electromed
- 7PulmonxThis companyNot disclosed
- 8CVRxNot disclosed
- 9Delcath SystemsNot disclosed
- 10Lemaitre VascularNot disclosed
- 11NeuroPaceNot disclosed
- 12NevroNot disclosed
- 13SI-BONENot disclosed
- 14Senseonics HoldingsNot disclosed
- 15Sight SciencesNot disclosed
- 16Silk Road MedicalNot disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.